Solid Bio wins new Buy at Guggenheim on lead asset
Source: SeekingAlpha
2026-03-20 10:24:02 ET
More on Solid Biosciences
- Solid Biosciences Inc. (SLDB) Presents at Barclays 28th Annual Global Healthcare Conference Transcript
- Solid Biosciences: Interim Data Lends Credibility For Q1 2026 Trial Start
- Solid Biosciences Inc. (SLDB) Presents at Guggenheim Securities Emerging Outlook: Biotech Summit 2026 Transcript
- Solid Bio falls amid new trial data for Duchenne drug
- Biotech firm stocks rise on FDA vaccine head’s exit
Read the full article on Seeking Alpha
For further details see:
Solid Bio wins new Buy at Guggenheim on lead asset
Roche Holding Ltd ADR
NASDAQ: RHHBY
RHHBY Trading
-0.2% G/L:
$48.13 Last:
1,348,624 Volume:
$47.65 Open:
RHHBY Latest News
March 24, 2026 02:00:00 am
Roche launches the cobas eplex respiratory pathogen panel 3, a fast and comprehensive test to help clinicians treat patients with respiratory infections, in CE markets
RHHBY Stock Data
$361,973,933,704
6,306,832,002
N/A
43
N/A
Pharmaceuticals
Healthcare
CH
Basel Switzerland
